Breaking News, Collaborations & Alliances

Lonza, Sartorius Modify Deal for Supply of Cell Culture Media

Sartorius Stedim Biotech will continue to offer Lonza media and buffer products but under a non-exclusive agreement

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Lonza and Sartorius Stedim Biotech (SSB) have modified their current agreement for supply of cell culture media by mutual accord. The agreement, signed in 2012, gave SSB exclusive sales and marketing rights for certain media and buffers developed and manufactured by Lonza for use in biopharmaceutical manufacturing processes. Lonza retained sales for research-based products, among others.   Under the new deal SSB will continue to offer current and future Lonza media and buffers on a non-exclusi...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters